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A B S T R A C TAn article by Lu et al. in this issue of Value in Health addresses the
mapping of treatment or group differences in disease-specific mea-
sures (DSMs) of health-related quality of life onto differences in generic
health-related quality-of-life scores, with special emphasis on how the
mapping is affected by the reliability of the DSM. In the proposed
mapping, a factor analytic model defines a conversion factor between
the scores as the ratio of factor loadings. Hence, the mapping applies to
convert true underlying scales and has desirable properties facilitating
the alignment of instruments and understanding their relationship in a
coherent manner. It is important to note, however, that when DSM
means or differences in mean DSMs are estimated, their mapping isee front matter Copyright & 2013, International S
r Inc.
.1016/j.jval.2012.07.009
wisc.edu.
ondence to: Mari Palta, Population Health Sciences,still of a measurement error–prone predictor, and the correct conver-
sion coefficient is the true mapping multiplied by the reliability of the
DSM in the relevant sample. In addition, the proposed strategy for
estimating the factor analytic mapping in practice requires assump-
tions that may not hold. We discuss these assumptions and how they
may be the reason we obtain disparate estimates of the mapping factor
in an application of the proposed methods to groups of patients.
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Measuring health-related quality of life (HRQOL) has become
standard in clinical trials of treatments and in studies assessing
the impact of health conditions. There is little agreement,
however, on the choice of instrument to achieve this. It is often
felt that disease-specific measures (DSMs) of HRQOL are most
sensitive to changes in HRQOL related to a specific condition or
disease. For example, the Minnesota Living with Heart Failure
(MLHF) questionnaire [1,2] may be chosen to assess the progress
of patients with congestive heart failure entering intensive
treatment, the 25-item National Eye Institute Visual Function
Questionnaire (NEI-VFQ-25) [3] to assess the benefit of eye
surgery, or the Beck Depression Inventory [4] to measure the
impact of a treatment for depression. However, it is desirable to
express treatment impact on HRQOL in terms that allow compar-
ison to other health conditions, and preference scoring for
application in cost-effectiveness analysis. When only a DSM
is available from a trial, there may be a need to convert (map or
cross-walk) the scores of the MLHF questionnaire to the EuroQol
five-dimensional (EQ-5D) questionnaire or other generic HRQOL
utility measure. In this issue of the journal, Lu et al. [5] address
methods for mapping DSMs into generic scores.
The word ‘‘mapping’’ has taken on several meanings, at least
two of which are relevant to Lu et al. [5] and this discussion. Thefirst is anticipated in the Introduction of Lu et al. [5], in which
‘‘mapping’’ is defined as ‘‘treatment effects estimated on the
disease-specific measure (DSM) are multiplied by a mapping
coefficient to convert them into treatment effect estimates on
the generic QOL scale.’’ What the authors end up developing,
however, is a second conceptual mapping applicable to the true,
not estimated, mean score or treatment effect. This second factor
loading–based mapping informs about the relationships between
what the instruments truly attempt to measure. Because it
pertains to a theoretical framework not mudded by measurement
error in a particular setting, it has more desirable properties. As
noted in Lu et al. [5], the framework has been used in educational
testing to ‘‘align instruments,’’ that is, to ascertain that they
fundamentally measure the same underlying abilities. One needs
to be clear about the distinction and how it affects the correct
way to perform a conversion in practice. In this commentary, I
attempt to clarify how the proposed methods may be put to use
and also further discuss the assumptions needed for the specific
methods proposed by Lu et al. [5].
Two different approaches to estimating the mapping between
true underlying means are proposed. (It should be noted that
models in Lu et al. [5] are actually not presented in terms of
differences, but in terms of group means, later to be differenced.)
Both approaches depend on the availability of data or results
from a separate study that measured the DSM and obtainedociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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Briefly, the first method fits a linear regression of the generic
score on the DSM and then applies corrections for measurement
error through knowing the reliability of the DSM. The second
method assumes that there are data on two generic scores
together with the DSM and that the two generic scores share
the aspect—and only the aspect—of health covered by the DSM.
Linear correlations are then used to extract a conversion factor.
We illustrate the impact of the assumptions by applying
the methods proposed in Lu et al. [5] to a study of the MLHF
questionnaire in congestive heart failure clinics and the NEI-VFQ-
25 in patients undergoing cataract extraction [6]. This study also
obtained simultaneous data on several generic instruments, as
well as repeated measures, allowing the extraction of reliability
coefficients for the MLHF questionnaire and the NEI-VFQ-25.Comment on Methods
The Role of Reliability in Mapping
The measurement error, reliability, and underlying factors of
HRQOL instruments have received relatively little attention in
the cost-effectiveness analysis and HRQOL literature, with some
exceptions [e.g., 7–10], and Lu et al. [5] should be lauded for
bringing renewed attention to these important measurement
aspects. As pointed out, in an ordinary regression analysis of a
generic HRQOL instrument on a DSM, the regression coefficient is
affected by the reliability of the DSM in the particular sample.
Specifically, the slope of the relationship is bx ¼ brx, where b is
the regression coefficient that would be obtained had the true
value of DSM been known and rx is the reliability of the predictor
X (i.e., DSM), obtainable, for example, from test/retest data.
Nonetheless, the equation using bx as the mapping slope is
correct (unbiased) for the particular study when X is either a
measured individual or an estimated mean score.
It is relevant to note that rx is the ratio sa
2/(sa
2 þ se2), where sa2 is
the variance between individuals in the true x (DSM) and se
2 is the
measurement error variance. Then, the estimated coefficient for
obtaining a generic score from a DSM may vary between studies
with different underlying sa
2 (i.e., spread in DSM), and formulating
the mapping as one between true values (i.e., in terms of b) is
advantageous. However, when DSM values measured in practice
are to be mapped, b still needs to be multiplied by a rx appro-
priate to the sample under consideration. In fact, it may be
desirable to build into a study the estimation of rx, for example,
via a test-retest component. When taking the mean of DSM
across a treatment group, both variance components become
averaged so that the reliability coefficient is
s2a
n
 
s2a
n
þ s
2
e
n
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which is identical to that of the initial measurement. Hence,
bx ¼ brx should be used in the mapping of estimated means,
albeit ideally with a rx modified to fit the specific study.
Role of Linearity of the Relationship
It should be noted that the estimation of the relationship
between the generic score and the DSM via bx ¼ brx depends on
the regression of the observed generic score on DSM being linear.
Given the strong ceiling effects in many generic scores, this
assumption may not hold, and bx across the range of X may
depend on the HRQOL distribution of the sample. Several
approaches to the linearity/ceiling effect problem have been
applied and investigated in the literature, such as using splines
[11], censored or latent class models [12], discretizing the scores[10], or fitting different models to different ranges of the DSM [5].
The mappings proposed [5] would need further work as to how
reliability would be estimated and applied in such models. It
should be noted that this problem is separate from the linearity
assumed in the factor analytic relationship, which is between
underlying unobserved constructs.
Assumptions in Using Two Generic Scores
Another proposed way to obtain the measurement error–
corrected mapping of the DSM onto a generic instrument
requires that the DSM be available in an auxiliary study together
with two generic instruments [5]. A rather strict assumption is
made that the components in the two instruments not captured
by the DSM are uncorrelated. In other words, the component(s)
the two generic instruments have in common are those and only
those captured by the DSM. One may envision that such an
assumption can be true if the DSM is comprehensive enough to
capture all standard domains of HRQOL. On the other hand, even
if the generic instruments capture all domains of the DSM
affected by the disease under study, it is possible that individuals
have other health condition, or even unexpected side effects of
treatment captured by both generic instruments, but not by the
DSM. In the latter case, the assumption would not hold. It has
been shown that many generic instruments have much variance
in common [9,10], requiring careful consideration before the
assumption of nonshared extraneous-to-DSM domains can
be made.
Equation 10 in Lu et al. [5] provides the estimator. For
consistency, we use X to denote values of the DSM, Q1 to denote
values of the generic instrument desired, and Q2 of the auxiliary
generic instrument:
b ¼ Sign of relationship  corrðQ1,Q2Þ
corrðQ1,XÞ


 
O VarðQ1Þ
VarðxÞ
 
In this formula, the expression under the square-root is
simply a conversion of the two instruments to the same scale,
and the sign converts, for example, a DSM scale where lower
value indicates better HRQOL to a generic scale where higher
value indicates better HRQOL. The ratio of correlations, however,
will capture the needed quantity only if corr(Q1,Q2) is not inflated
by shared extraneous-to-DSM factors. The feasibility of the
assumption likely depends on the level of health in the sample
used, as generic instruments have been shown to capture under-
lying dimensions differentially at different levels of health [9].
Ceiling effects in Q1 can reduce the linear correlation between Y
and Q1, possibly more so than the correlation between Q1 and
Q2, where ceiling may be shared. It is difficult to assess the
impact of the linearity assumption between Q1 and X, except to
note that nonlinearity-based bias in the directly reliability
adjusted and the two-instrument–based estimators will be in
opposite directions, as the linear relationship is in the numerator
of the former and in the denominator of the latter.Results of Application
Problems arising with the assumptions discussed above can be
summarized as 1) a linear relationship between the measured
generic score and the DSM may not hold because of ceiling
effects in most generic scores and 2) generic scores may share
health dimensions not measured by the DSM, except for specific
DSMs and generic scores. We now turn to examining the
performance of the methods in a patient sample evaluated with
a number of HRQOL measures [6].
The Clinical Outcomes and Measurement of Health Study [6]
provides longitudinal data on the NEI-VFQ-25 [3] in a group of
Table 1 – Estimated mapping coefficients of two disease-specific measures into the EQ-5D questionnaire.
Reliability
adjusted
By
SF36P
By
SF36M
By
SF-6D
By
HUI3
By
QWB-SA
The MLHF questionnaire to the EQ-5D
questionnaire (n ¼ 77)
 0.0069  0.0072  0.0060  0.0083  0.0077  0.0078
Partial on the MLHF questionnaire
correlation with the EQ-5D
questionnaire
0.44 0.24 0.54 0.54 0.46
NEI-VFQ-25 to the EQ-5D
questionnaire (n ¼ 191)
0.0092 0.021 0.016 0.024 0.024 0.023
Partial on NEI-VFQ-25 correlation with
the EQ-5D questionnaire
0.53 0.31 0.52 0.52 0.49
EQ-5D, EuroQol five-dimensional; HUI3, health utilities index mark 3; MLHF, Minnesota Living with Heart Failure; NEI-VFQ-25, the 25-item
National Eye Institute Visual Function Questionnaire; SF36P, short form 36 physical component; SF36M, short form 36 mental component;
SF-6D, six-dimensional health state short form (derived from short form 36 health survey); QWB-SA, Quality of Well Being Self-Administered.
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tionnaire [1,2] for a group entering clinics to manage conges-
tive heart failure. As individuals were measured at three time
points (baseline, 1 month, and 6 months), we estimate relia-
bility from the last two visits, and map the NEI-VFQ-25 and the
MLHF questionnaire, respectively, onto the EQ-5D question-
naire at 1 month. Our reliability of the NEI-VFQ-25 was
estimated at 0.72 and that of the MLHF questionnaire at
0.75, the former within published range for individual scales
of 0.68 to 0.91 and the latter somewhat lower than published
0.86 [2,3]. As the study also administered the short form 36
health survey version 2, six-dimensional health state short
form (derived from short form 36 health survey), health
utilities index mark 3, and the Quality of Well Being Self-
Administered (QWB-SA) scale [13–16], we use each of these as a
secondary instrument. At face value, both the NEI-VFQ-25 and
the MLHF questionnaire share considerable content with the
generic instruments.
Results of applying the methods proposed in Lu et al. [5] to
individuals who provided data on all instruments at 1-month
follow-up are shown in Table 1, together with partial correlations
of generic instruments with the EQ-5D questionnaire (all
Po 0.05). Note that because the intention is to apply the conver-
sion to treatment differences, intercepts are not needed. We see
that for the NEI-VFQ-25 the method based on two generic
instruments tends to yield considerably higher coefficients than
the reliability-based method, while the results are more consis-
tent for the MLHF questionnaire. We note the following: 1) The
EQ-5D questionnaire has a strong ceiling effect in the cataract
surgery sample (38% have value ¼ 1) and a moderate ceiling in
the congestive heart failure sample (19%). The reliability-based
NEI-VFQ-25 conversion is likely underestimated, at least in the
cataract surgery sample. 2) The correlation of the EQ-5D question-
naire with NEI-VFQ-25 is only 0.41, while the correlation with the
MLHF questionnaire is 0.70; this may have affected the stability of
the mapping in the cataract sample. 3) Only health utilities
index mark 3 shares with the EQ-5D questionnaire a sharply
skewed distribution in these samples. However, the results
using health utilities index mark 3 do not differ from those
using other instruments with no notable ceiling, perhaps indi-
cating that joint content is the most important issue. 4) The
mental short form 36 health survey component also utilized by
Lu et al. [5] has the lowest partial correlation. 5) We have
previously shown that especially the QWB-SA shares consider-
able content with the Minnesota Living With Heart Failure
Questionnaire (LHFQ) [17]. Despite this, the partial correlation
with the EQ-5D questionnaire is nonnegligible.Future Directions
More attention needs to be paid to improving the reliability of
HRQOL measures, which is generally quite low [8]. Outcome
studies should incorporate test-retest features into their design
to directly assess reliability in their population. Furthermore,
much more attention to the underlying structures of DSMs versus
generic measures is needed. Our application together with that in
Lu et al. [5] illustrates the difficulties of knowing whether
assumptions hold. Possibly the mappings envisioned by Lu
et al. [5] would be more fruitfully applied directly in a latent
variable framework than estimated by making the present
assumptions. The fact that DSMs are needed at all is thought
provoking, and more research is needed into the overlap or lack
thereof with generic scales.
Finally, a method of regression analysis needs to be agreed
upon that accommodates ceiling effects. It appears that simply
allowing censoring at the maximum value is not sufficient [12].
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